Provided by Tiger Trade Technology Pte. Ltd.

Evelo Biosciences

0.0001
0.0000
Volume:- -
Turnover:- -
Market Cap:1.90K
PE:0.00
High:0.0001
Open:0.0001
Low:0.0001
Close:0.0001
52wk High:0.0025
52wk Low:0.0000
Shares:18.98M
Float Shares:16.74M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-9.6476
EPS(LYR):-26.2771
ROE:-6232.76%
ROA:-83.25%
PB:-0.00
PE(LYR):0.00

Loading ...

Company Profile

Company Name:
Evelo Biosciences
Exchange:
EXPERT
Establishment Date:
2014
Employees:
66
Office Location:
600/700, One Kendall Square,Suite 7-201,Cambridge,Massachusetts,United States
Zip Code:
02139
Fax:
- -
Introduction:
Evelo Biosciences, Inc., a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis. The company is also developing EDP1867, a non-live pharmaceutical preparation for single strain of Veillonella parvula, which is in Phase 1b clinical trial; EDP2939, an investigational oral biologic for the potential treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.